Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Psoriasis Pathogenesis and Treatment
Adriana Rendón, Knut Schäkel
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 6, pp. 1475-1475
Open Access | Times Cited: 1589

Showing 1-25 of 1589 citing articles:

The Role of Tumor Necrosis Factor Alpha (TNF-α) in Autoimmune Disease and Current TNF-α Inhibitors in Therapeutics
Dan-in Jang, A-Hyeon Lee, Hye-Yoon Shin, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 5, pp. 2719-2719
Open Access | Times Cited: 985
Advances in the pathogenesis of psoriasis: from keratinocyte perspective
Xue Zhou, Youdong Chen, Lian Cui, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 329
The Prevalence of Autoimmune Disorders in Women: A Narrative Review
Fariha Angum, Tahir Mehmood Khan, Jasndeep Kaler, et al.
Cureus (2020)
Open Access | Times Cited: 302
Sulfoximines as Rising Stars in Modern Drug Discovery? Current Status and Perspective on an Emerging Functional Group in Medicinal Chemistry
Patrick Mäder, Lars Kattner
Journal of Medicinal Chemistry (2020) Vol. 63, Iss. 23, pp. 14243-14275
Closed Access | Times Cited: 278
New Treatment Addressing the Pathogenesis of Psoriasis
Michio Tokuyama, Tomotaka Mabuchi
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 20, pp. 7488-7488
Open Access | Times Cited: 216
Pathological angiogenesis: mechanisms and therapeutic strategies
Andrew C. Dudley, Arjan W. Griffioen
Angiogenesis (2023) Vol. 26, Iss. 3, pp. 313-347
Open Access | Times Cited: 212
An update on generalized pustular psoriasis
Melinda Gooderham, Abby S. Van Voorhees, Mark Lebwohl
Expert Review of Clinical Immunology (2019) Vol. 15, Iss. 9, pp. 907-919
Open Access | Times Cited: 193
Current Developments in the Immunology of Psoriasis.
Franziska Grän, Andreas Kerstan, Edgar Serfling, et al.
The Yale Journal of Biology and Medicine (2020) Vol. 93, Iss. 1, pp. 97-110
Closed Access | Times Cited: 173
Use of IL-23 Inhibitors for the Treatment of Plaque Psoriasis and Psoriatic Arthritis: A Comprehensive Review
Kevin Yang, Allen S. W. Oak, Boni E. Elewski
American Journal of Clinical Dermatology (2020) Vol. 22, Iss. 2, pp. 173-192
Open Access | Times Cited: 144
Inhibition of keratinocyte ferroptosis suppresses psoriatic inflammation
Yanhong Shou, Lu Yang, Yongsheng Yang, et al.
Cell Death and Disease (2021) Vol. 12, Iss. 11
Open Access | Times Cited: 135
Signaling pathways and targeted therapies for psoriasis
Jia Guo, H. Zhang, Wenrui Lin, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 118
The Cytokine Mediated Molecular Pathophysiology of Psoriasis and Its Clinical Implications
Rohan Singh, Sindhuja Koppu, Patrick O. Perche, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 23, pp. 12793-12793
Open Access | Times Cited: 109
Self‐Powered Controllable Transdermal Drug Delivery System
Yuan Yang, Lingling Xu, Dongjie Jiang, et al.
Advanced Functional Materials (2021) Vol. 31, Iss. 36
Closed Access | Times Cited: 107
Current Concepts of Psoriasis Immunopathogenesis
Marijana Vičić, Marija Kaštelan, Ines Brajac, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 21, pp. 11574-11574
Open Access | Times Cited: 105
The interaction between nanoparticles and immune system: application in the treatment of inflammatory diseases
Jin Liu, Zeyang Liu, Yan Pang, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 102
The Anti-Inflammatory and Immunomodulatory Activities of Natural Products to Control Autoimmune Inflammation
Kamal D. Moudgil, Shivaprasad H. Venkatesha
International Journal of Molecular Sciences (2022) Vol. 24, Iss. 1, pp. 95-95
Open Access | Times Cited: 95
Pathophysiology of Generalized Pustular Psoriasis
Slaheddine Marrakchi, L. Puig
American Journal of Clinical Dermatology (2022) Vol. 23, Iss. S1, pp. 13-19
Open Access | Times Cited: 86
The Involvement of Oxidative Stress in Psoriasis: A Systematic Review
Elena-Codruța Dobrică, Matei-Alexandru Cozma, Mihnea‐Alexandru Găman, et al.
Antioxidants (2022) Vol. 11, Iss. 2, pp. 282-282
Open Access | Times Cited: 75
Gut Microbiota in Psoriasis
Mihaela Cristina Buhaș, Laura Ioana Gavrilaș, Rareș Candrea, et al.
Nutrients (2022) Vol. 14, Iss. 14, pp. 2970-2970
Open Access | Times Cited: 72
Type 1 Diabetes Mellitus and Autoimmune Diseases: A Critical Review of the Association and the Application of Personalized Medicine
Mihaela Simona Popoviciu, Nirja Kaka, Yashendra Sethi, et al.
Journal of Personalized Medicine (2023) Vol. 13, Iss. 3, pp. 422-422
Open Access | Times Cited: 72
Apigenin: A Therapeutic Agent for Treatment of Skin Inflammatory Diseases and Cancer
Ji Hye Yoon, Mi‐Yeon Kim, Jae Youl Cho
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1498-1498
Open Access | Times Cited: 62
The role of short-chain fatty acids in inflammatory skin diseases
Xianjun Xiao, Xiaoshen Hu, Junpeng Yao, et al.
Frontiers in Microbiology (2023) Vol. 13
Open Access | Times Cited: 57
Polymeric Nanoparticles as Tunable Nanocarriers for Targeted Delivery of Drugs to Skin Tissues for Treatment of Topical Skin Diseases
Eiman Abdalla Madawi, Alaa Raad Al Jayoush, Mutasem Rawas‐Qalaji, et al.
Pharmaceutics (2023) Vol. 15, Iss. 2, pp. 657-657
Open Access | Times Cited: 56
Curcumin-Based Nanomedicines in the Treatment of Inflammatory and Immunomodulated Diseases: An Evidence-Based Comprehensive Review
Lucas Fornari Laurindo, Gabriel Magno de Carvalho, Bárbara de Oliveira Zanuso, et al.
Pharmaceutics (2023) Vol. 15, Iss. 1, pp. 229-229
Open Access | Times Cited: 50
Early disease intervention with guselkumab in psoriasis leads to a higher rate of stable complete skin clearance (‘clinical super response’): Week 28 results from the ongoing phase IIIb randomized, double‐blind, parallel‐group, GUIDE study
Knut Schäkel, Kristian Reich, K. Asadullah, et al.
Journal of the European Academy of Dermatology and Venereology (2023) Vol. 37, Iss. 10, pp. 2016-2027
Open Access | Times Cited: 44
Page 1 - Next Page

Scroll to top